Fanconi syndrome induced by vemurafenib: A newrenal adverse event

JAMA Dermatology

Volumn 151, Issue 4, 2015, Pages 453-454

  Denis, Daphné ^a   Franck, Nathalie ^a   Fichel, Fanny ^a   Levi, Charlène ^b   Dupin, Nicolas ^a  

^a Institut Cochin   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DABRAFENIB; POTASSIUM; VEMURAFENIB; ANTINEOPLASTIC AGENT; INDOLE DERIVATIVE; SULFONAMIDE;

AGED; CASE REPORT; DARIER DISEASE; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG WITHDRAWAL; EOSINOPHILIA; FANCONI RENOTUBULAR SYNDROME; FEVER; HUMAN; HYPERURICOSURIA; HYPOKALEMIA; HYPOPHOSPHATEMIA; HYPOURICEMIA; KALIURESIS; LETTER; LIVER METASTASIS; LYMPH NODE METASTASIS; MACULOPAPULAR RASH; MALE; MELANOMA; PHOTOSENSITIVITY; PRIORITY JOURNAL; SUPPLEMENTATION; CHEMICALLY INDUCED; PATHOLOGY; SKIN NEOPLASMS;

AGED; ANTINEOPLASTIC AGENTS; FANCONI SYNDROME; HUMANS; INDOLES; MALE; MELANOMA; SKIN NEOPLASMS; SULFONAMIDES;

EID: 84928227183     PISSN: 21686068     EISSN: 21686084     Source Type: Journal    
DOI: 10.1001/jamadermatol.2014.4529     Document Type: Letter

References (6)

1. US Food and Drug Administration. Highlights of prescribing information: Zelboraf. http://www.accessdata.fda.gov/drugsatfda-docs/label/2011/202429s000lbl.pdf. Accessed February 20, 2014.
2. Uthurriague C, Thellier S, Ribes D, Rostaing L, Paul C, Meyer N. Vemurafenib significantly decreases glomerular filtration rate. J Eur Acad Dermatol Venereol. 2014;28(7):978-979.
3. Regnier-Rosencher E, Lazareth H, Gressier L, Avril MF, Thervet E, Dupin N. Acute kidney injury in patients with severe rash on vemurafenib treatment for metastatic melanomas. Br J Dermatol. 2013;169(4):934-938.
4. Launay-Vacher V, Zimner-Rapuch S, Poulalhon N, et al. Acute renal failure associated with the new BRAF inhibitor vemurafenib: a case series of 8 patients. Cancer. 2014;120(14):2158-2163.
5. Izzedine H, Launay-Vacher V, Isnard-Bagnis C, Deray G. Drug-induced Fanconi's syndrome. Am J Kidney Dis. 2003;41(2):292-309.
6. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156(3):609-611.